New guidelines, and a new hypertensive population How to select women for menopausal hormone therapy

Abstract

The 2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults published in November 2017(1) designates new categories of blood pressure in adults: Normal <120/140/>90 mm Hg. A previous report based on blood pressure readings in 19.1 million adults pooled from 1 479 studies found that the global age-standardized prevalence of raised blood pressure was 24.1% (21.4–27.1) in men and 20.1% (17.8–22.5) in women in 2015(2). The Peruvian Tornasol II study on Risk Factors for Cardiovascular Diseases reported in 2011 a prevalence of 27.3% for arterial hypertension(3), showing an increase compared to the previous value of 23.7% in 2006(4).

Del Editor sobre la Salud de la Mujer, embarazo, complicaciones, futuro

“…The programmed death ligand 1 (PD-L1) antibody atezolizumab has been found to be beneficial for those with triple-negative breast cancer expressing PD-L1. Recently updated American College of Cardiology/ American Heart Association (ACC/AHA) guidelines redefine blood pressure categories as Stage 1 hypertension (systolic 130-139mmHg or diastolic 80-89mmHg), Elevated (systolic 120-129mmHg and diastolic <80mm) and Normal (<120/<80 mmHg), but their relevance to the obstetric population is uncertain (20) . A prospective observational study of 8 899 nulliparous women with singleton pregnancies was conducted at eight clinical sites; the first study visit occurred at a mean gestational age (GA) of 11.6 ± 1.5 weeks and the second one, at a mean GA of 19.0 ± 1.6 weeks.…”